|
1
|
Noto H, Goto A, Tsujimoto T and Noda M:
Cancer risk in diabetic patients treated with metformin: A
systematic review and meta analysis. PLoS One. 7:e334112012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Decensi A, Puntoni M, Goodwin P, Cazzaniga
M, Gennari A, Bonanni B and Gandini S: Metformin and cancer risk in
diabetic patients: A systematic review and meta analysis. Cancer
Prev Res (Phila). 3:1451–1461. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gandini S, Puntoni M, Heckman-Stoddard BM,
Dunn BK, Ford L, DeCensi A and Szabo E: Metformin and cancer risk
and mortality: A systematic review and meta-analysis taking into
account biases and confounders. Cancer Prev Res (Phila). 7:867–885.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hardie DG, Ross FA and Hawley SA: AMPK: A
nutrient and energy sensor that maintains energy homoestasis. Nat
Rev Mol Cell Biol. 13:251–262. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pollak MN: Investigating metformin for
cancer prevention and treatment: The end of the beginning. Cancer
Discov. 2:778–790. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pollak M: The insulin and insulin-like
growth factor receptor family in neoplasia; An update. Nat Rev
Cancer. 12:159–169. 2012.PubMed/NCBI
|
|
7
|
Gallagher EJ and Le Roith D: Diabetes,
cancer, and metformin: Connections of metabolism and cell
proliferation. Ann N Y Acad Sci. 1243:54–68. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thompson MD, Grubbs CJ, Bode AM, Reid JM,
McGovern R, Bernard PS, Stijleman IJ, Green JE, Bennett C, Juliana
MM, et al: Lack of effect of metformin on mammary carcinogenesis in
nondiabetic rat and mouse models. Cancer Prev Res (Phila).
8:231–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu Z, Jiang W, Thompson MD, Echeverria D,
McGinley JN and Thompson HJ: Effects of metformin, buformin, and
phenformin on the post-initiation stage of chemically induced
mammary carcinogenesis in the rat. Cancer Prev Res (Phila).
8:518–527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lubet RA, Steele VE, Juliana MM and Grubbs
CJ: Screening agents for preventive efficacy in a bladder cancer
model: Study design, end points, and gefitinib and naproxen
efficacy. J Urol. 183:1598–1603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu Y, Liu P, Wen W, Grubbs CJ, Townsend
RR, Malone JP, Lubet RA and You M: Cross-species comparison of
orthologous gene expression in human bladder cancer and
carcinogen-induced rodent models. Am J Transl Res. 3:8–27.
2010.PubMed/NCBI
|
|
12
|
McCormick DL, Phillips JM, Horn TL,
Johnson WD, Steele VE and Lubet RA: Overexpression of
cyclooxygenase-2 in rat oral cancers and prevention of oral
carcinogenesis in rats by selective and nonselective COX
inhibitors. Cancer Prev Res (Phila). 3:73–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng X, Li W, Johnson WD, Torres KE and
McCormick DL: Overexpression of lipocalins and pro-inflammatory
chemokines and altered methylation of PTGS2 and APC2 in oral
squamous cell carcinomas induced in rats by
4-nitroquinoline-1-oxide. PLoS One. 10:e01162852015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cooper HS, Chang WC, Coudry R, Gary MA,
Everly L, Spittle CS, Wang H, Litwin S and Clapper ML: Generation
of a unique strain of multiple intestinal neoplasia
(Apc(+/Min-FCCC)) mice with significantly increased numbers of
colorectal adenomas. Mol Carcinog. 44:31–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McCormick DL, Horn TL, Johnson WD, Peng X,
Lubet RA and Steele VE: Suppression of rat oral carcinogenesis by
agonists of peroxisome proliferator activated receptor γ. PLoS One.
10:e01418492015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lubet RA, Clapper ML, McCormick DL,
Pereira MA, Chang WC, Steele VE, Fischer SM, Juliana MM and Grubbs
CJ: Chemopreventive efficacy of Targretin in rodent models of
urinary bladder, colon/intestine, head and neck and mammary
cancers. Oncol Rep. 27:1400–1406. 2012.PubMed/NCBI
|
|
17
|
Giovannucci E, Harlan DM, Archer MC,
Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG and
Yee D: Diabetes and cancer: A consensus report. CA Cancer J Clin.
60:207–221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Evans JM, Donnelly LA, Emslie-Smith AM,
Alessi DR and Morris AD: Metformin and reduced risk of cancer in
diabetic patients. BMJ. 330:1304–1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jones RG, Plas DR, Kubek S, Buzzai M, Mu
J, Xu Y, Birnbaum MJ and Thompson CB: AMP-activated protein kinase
induces a p53-dependent metabolic checkpoint. Mol Cell. 18:283–293.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pollak M: Metformin and other biguanides
in oncology: Advancing the research agenda. Cancer Prev Res
(Phila). 3:1060–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tucker GT, Casey C, Phillips PJ, Connor H,
Ward JD and Woods HF: Metformin kinetics in healthy subjects and in
patients with diabetes mellitus. Br J Clin Pharmacol. 12:235–246.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martin-Castillo B, Vazquez-Martin A,
Oliveras-Ferraros C and Menendez JA: Metformin and cancer: Doses,
mechanisms and the dandelion and hormetic phenomena. Cell Cycle.
9:1057–1064. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Williams PD, Lee JK and Theodorescu D:
Molecular credentialing of rodent bladder carcinogenesis models.
Neoplasia. 10:838–846. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang T, Guo P, Zhang Y, Xiong H, Yu X, Xu
S, Wang X, He D and Jin X: The antidiabetic drug metformin inhibits
the proliferation of bladder cancer cells in vitro and in vivo.
Intl J Mol Sci. 14:24603–24618. 2013. View Article : Google Scholar
|
|
25
|
Peng M, Su Q, Zeng Q, Li L, Liu Z, Xue L,
Cheng Y, Huang Y, Tao T, Lv H, et al: High efficacy of
intravescicular treatment of metformin on bladder cancer in
preclinical model. Oncotarget. 7:9102–9117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Q, Yuan W, Tong D, Liu G, Lan W, Zhang
D, Xiao H, Zhang Y, Huang Z, Yang J, et al: Metformin represses
bladder cancer progression by inhibiting stem cell repopulation via
COX2/PGE2/STAT3 axis. Oncotarget. 7:28235–28246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fischer SM, Hawk ET and Lubet RA: Coxibs
and other nonsteroidal anti-inflammatory drugs in animal models of
cancer chemoprevention. Cancer Prev Res (Phila). 4:1728–1735. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tomimoto A, Endo H, Sugiyama M, Fujisawa
T, Hosono K, Takahashi H, Nakajima N, Nagashima Y, Wada K, Nakagama
H and Nakajima A: Metformin suppresses intestinal polyp growth in
ApcMin/+ mice. Cancer Sci. 99:2136–2141. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dowsett M, Nielsen TO, A'Hern R, Bartlett
J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, et
al: Assessment of Ki67 in breast cancer: Recommendations from the
International Ki67 in breast cancer working group. J Natl Cancer
Inst. 103:1656–1664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hadad S, Iwamoto T, Jordan L, Purdie C,
Bray S, Baker L, Jellema G, Deharo S, Hardie DG, Pusztai L, et al:
Evidence for biological effects of metformin in operable breast
cancer: A pre-operative, window-of-opportunity, randomized trial.
Breast Cancer Res Treat. 128:783–794. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Algire C, Amrein L, Zakikhani M, Panasci L
and Pollak M: Metformin blocks the stimulative effect of a
high-energy diet on colon carcinoma growth in vivo and is
associated with reduced expression of fatty acid synthase. Endocr
Relat Cancer. 17:351–360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bonanni B, Putoni M, Cazzaniga M, Pruneri
G, Serrano D, Guerrieri-Gonzaga A, Gennari A, Trabacca MS,
Galimberti V, Veronesi P, et al: Dual effect of metformin on breast
cancer proliferation in a randomized presurgical trial. J Clin
Oncol. 30:2593–2600. 2012. View Article : Google Scholar : PubMed/NCBI
|
